ALS group launches trial of digital app to track progression

A new mobile app could help patients, physicians and drug developers track amyotrophic lateral sclerosis disease progression to better understand whether an investigational therapy is working and learn more about the natural history of the disease.

The ALS Never Surrender Foundation will start trials this month of the iNVOLVE/eNGAGE app in 50 ALS patients across five U.S. clinics. The app uses technologies from Google AI, IBM Watson and Apple Inc. (NASDAQ:APPL) to capture physical data including information on muscle control, dexterity, breathing, speech and other key vital statistics on patients with ALS totaling more than 80 different metrics. ...